The contraceptives market in Poland, based on hormones or spermicides, has seen a significant decline in market value from 2012 to 2022, with a peak value of $133.03 million in 2012 decreasing to $70.107 million in 2022. This represents an overall downward trend. The market experienced the most dramatic year-on-year variations during 2014 (-21.46%) and 2022 (-14.36%), reflecting considerable market volatility.
Despite some minor upticks in 2018 (4.08%) and 2019 (1.56%), the overall compounded annual growth rate (CAGR) over the past 5 years (2018-2022) indicates a significant decline of -2.96%. In the last two years, the market continued to shrink with values falling year-on-year by -3.92% in 2020, -1.09% in 2021, and dropping sharply by -14.36% in 2022.
Looking ahead to 2024, future trends to watch for include potential regulatory changes, the introduction of new technologies or products in the contraceptives sector, shifting consumer preferences, and demographic changes which could impact market demand. Additionally, monitoring the accessibility and public health policies related to contraceptives may offer insights into the market’s direction.
How does Poland rank in Contraceptives (Based on Hormones or Spermicides) Market Size Value?
| # | 17 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 483,630,000 | 2023 | -0.78% | -0.58% | View data |
| 2 | 2 Argentina | 368,560,000 | 2023 | +2.14% | +3.2% | View data |
| 3 | 3 Italy | 242,670,000 | 2023 | -8.82% | -9.17% | View data |
| 4 | 4 Spain | 214,090,000 | 2023 | -11.7% | -7.16% | View data |
| 5 | 5 Chile | 123,060,000 | 2023 | -0.61% | -1.89% | View data |
| 6 | 6 Thailand | 74,049,000 | 2023 | -0.41% | +0.22% | View data |
| 7 | 7 Poland | 65,882,000 | 2023 | -6.03% | -4.93% | |
| 8 | 8 Switzerland | 62,127,000 | 2023 | -5.57% | -3.62% | View data |
| 9 | 9 Ukraine | 42,988,000 | 2023 | -0.81% | -0.71% | View data |
